141 related articles for article (PubMed ID: 12623241)
1. The extended pharmaceutical enterprise.
Cavalla D
Drug Discov Today; 2003 Mar; 8(6):267-74. PubMed ID: 12623241
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials in India.
Maiti R; M R
Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical futures: made in China?
Cyranoski D
Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994
[No Abstract] [Full Text] [Related]
4. To outsource in lead discovery: the devil or the deep blue sea?
Mander T; Turner R
J Biomol Screen; 2000 Jun; 5(3):113-8. PubMed ID: 10894753
[No Abstract] [Full Text] [Related]
5. Aspects of research and development contract terms in the bio/pharmaceutical sector.
Banerjee T
Adv Health Econ Health Serv Res; 2012; 23():1-33. PubMed ID: 23156659
[TBL] [Abstract][Full Text] [Related]
6. Biomanufacturing, from bust to boom...to bubble?
Thiel KA
Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
[No Abstract] [Full Text] [Related]
7. The quiet revolution: outsourcing in pharma.
Crossley R
Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
[No Abstract] [Full Text] [Related]
8. Pharmaceutical new product development: the increasing role of in-licensing.
Edwards NV
Anesthesiol Clin; 2008 Dec; 26(4):627-36, v. PubMed ID: 19041620
[TBL] [Abstract][Full Text] [Related]
9. A firm shift.
Nature; 2017 Dec; 552(7683):S6-S7. PubMed ID: 29219987
[No Abstract] [Full Text] [Related]
10. Outsourcing lead optimization: the eye of the storm.
Clark DE
Drug Discov Today; 2011 Feb; 16(3-4):147-57. PubMed ID: 21145413
[TBL] [Abstract][Full Text] [Related]
11. Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.
Sariola S; Ravindran D; Kumar A; Jeffery R
Soc Sci Med; 2015 Apr; 131():239-46. PubMed ID: 25476783
[TBL] [Abstract][Full Text] [Related]
12. Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization.
DeCorte BL
J Med Chem; 2020 Oct; 63(20):11362-11367. PubMed ID: 32479727
[TBL] [Abstract][Full Text] [Related]
13. Bioanalytical outsourcing: transitioning from Pharma to CRO.
Hayes R
Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
[No Abstract] [Full Text] [Related]
14. Outsourcing discovery.
Mallapaty S
Nature; 2017 Dec; 552(7683):S5. PubMed ID: 29219992
[No Abstract] [Full Text] [Related]
15. Biopharma CRO industry in China: landscape and opportunities.
Xia C; Gautam A
Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
[TBL] [Abstract][Full Text] [Related]
16. BioAsia Licensing and Deal-Making Summit-SRI Conference. Life science partnering and investment on the Pacific Rim 2-3 August, 2004, Coronado, CA, USA.
Xu J
IDrugs; 2004 Sep; 7(9):841-5. PubMed ID: 15470601
[TBL] [Abstract][Full Text] [Related]
17. The promise of the East: India and China as R&D options.
Goodall S; Janssens B; Wagner K; Wong J; Woods W; Yeh M
Nat Biotechnol; 2006 Sep; 24(9):1061-4. PubMed ID: 17061321
[No Abstract] [Full Text] [Related]
18. Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry.
Dierks RML; Bruyère O; Reginster JY
Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):147-160. PubMed ID: 29243501
[TBL] [Abstract][Full Text] [Related]
19. Bioanalytical outsourcing models in pharmaceutical companies.
Zimmer D
Bioanalysis; 2017 Aug; 9(15):1145-1148. PubMed ID: 28763250
[No Abstract] [Full Text] [Related]
20. The power of many.
Sansom C
Nat Biotechnol; 2011 Mar; 29(3):201-3. PubMed ID: 21390017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
